Reach your Investigational New Drug Application (IND) milestone with Quotient Sciences

Eleanor Row
Drug Substance

How to Accelerate Your Molecule’s Pathway to IND and Beyond

Read Blog
Let's talk about your drug program

Achieve your molecule’s full potential with our extensive experience in drug development, manufacturing & clinical testing

As an integrated CDMO and CRO provider with more than 30 years of experience working on small molecule and peptide drug development programs, we can help your path forward. 

Here are some of the ways we can help:

  • Drug Substance Synthesis & Manufacturing

A streamlined approach to developing drug substance that can help reduce costs by 50% from preclinical to Phase I.

  • Preclinical Technology Screening

Even before entering clinical evaluation stages, new therapeutics must overcome higher solubility hurdles.

  • Formulation Development

A range of services to help create your ideal drug product formulation and get ready to start your first-in-human clinical testing. 

Go further with Quotient Sciences
Preclinical Technology Screening
Identify and progress your molecule from preclinical to clinical testing.
Explore Service
Drug Substance Synthesis & Manufacturing
Comprehensive capabilities, including route scouting, PR&D, small-scale GMP manufacture, DOE/QbD, and 14C labelling.
Explore More
Translational Pharmaceutics® Integrated Drug Development
Our unique approach to drug development accelerates the entire process by integrating clinical activities and real-time cGMP manufacturing.
Discover More
Drug Product Development & Manufacturing
Tailored services, from formulation development to clinical trial manufacturing and commercial production.
Discover More